Back to Search Start Over

Progression of brain atrophy in spinocerebellar ataxia type 2: A longitudinal tensor-based morphometry study

Authors :
Mario Mascalchi
Nicola Toschi
Stefano Diciotti
Maria Teresa Dotti
Marco Aiello
Carlo Tessa
Emanuele Nicolai
Andrea Soricelli
Elena Salvatore
Lucia Galli
Silvia Piacentini
Andrea Ginestroni
Marco Giannelli
Mascalchi, M
Diciotti, S
Giannelli, M
Ginestroni, A
Soricelli, A
Nicolai, E
Aiello, M
Tessa, C
Galli, L
Dotti, Mt
Piacentini, S
Salvatore, Elena
Toschi, N.
Mario Mascalchi
Stefano Diciotti
Marco Giannelli
Andrea Ginestroni
Andrea Soricelli
Emanuele Nicolai
Marco Aiello
Carlo Tessa
Lucia Galli
Maria Teresa Dotti
Silvia Piacentini
Elena Salvatore
Nicola Toschi
Source :
PLoS ONE, Vol 9, Iss 2, p e89410 (2014), PLoS ONE
Publication Year :
2014

Abstract

Spinocerebellar ataxia type 2 (SCA2) is the second most frequent autosomal dominant inherited ataxia worldwide. We investigated the capability of magnetic resonance imaging (MRI) to track in vivo progression of brain atrophy in SCA2 by examining twice 10 SCA2 patients (mean interval 3.6 years) and 16 age- and gender-matched healthy controls (mean interval 3.3 years) on the same 1.5 T MRI scanner. We used T1-weighted images and tensor-based morphometry (TBM) to investigate volume changes and the Inherited Ataxia Clinical Rating Scale to assess the clinical deficit. With respect to controls, SCA2 patients showed significant higher atrophy rates in the midbrain, including substantia nigra, basis pontis, middle cerebellar peduncles and posterior medulla corresponding to the gracilis and cuneatus tracts and nuclei, cerebellar white matter (WM) and cortical gray matter (GM) in the inferior portions of the cerebellar hemisphers. No differences in WM or GM volume loss were observed in the supratentorial compartment. TBM findings did not correlate with modifications of the neurological deficit. In conclusion, MRI volumetry using TBM is capable of demonstrating the progression of pontocerebellar atrophy in SCA2, supporting a possible role of MRI as biomarker in future trials.

Details

Language :
English
Database :
OpenAIRE
Journal :
PLoS ONE, Vol 9, Iss 2, p e89410 (2014), PLoS ONE
Accession number :
edsair.doi.dedup.....ecb649c138fbdf5ec30978aee8fa262d